AMGEN INC. 2023-2024 Proxy Voting Records

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Wanda M. Austin”): 393,786,163 for, 4,305,331 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 157,868,246 for, 405,516 against, 106,540 abstained, 34 not voted, 2,120 unknown.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Robert A. Bradway”): 372,322,447 for, 24,802,538 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 158,166,301 for, 109,318 against, 106,542 abstained, 34 not voted, 261 unknown.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Michael V. Drake”): 391,321,469 for, 6,684,450 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 158,028,133 for, 247,746 against, 106,544 abstained, 34 not voted.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Brian J. Druker”): 394,741,846 for, 3,279,694 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 157,868,298 for, 405,461 against, 106,544 abstained, 34 not voted, 2,120 unknown.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Robert A. Eckert”): 377,035,518 for, 20,940,310 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 157,350,610 for, 923,147 against, 106,545 abstained, 34 not voted, 2,120 unknown.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Greg C. Garland”): 385,520,806 for, 12,454,659 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 156,868,935 for, 1,404,823 against, 106,544 abstained, 34 not voted, 2,120 unknown.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr.

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Charles M. Holley, Jr.”): 383,618,321 for, 14,367,464 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 158,027,735 for, 248,143 against, 106,545 abstained, 34 not voted.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak

AMGEN INC.’s own tally for this item (“Elect Director: Dr. S. Omar Ishrak”): 394,581,111 for, 3,432,313 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 157,868,289 for, 405,469 against, 106,544 abstained, 34 not voted, 2,120 unknown.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Tyler Jacks”): 387,382,721 for, 10,629,702 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 157,602,175 for, 671,583 against, 106,544 abstained, 34 not voted, 2,120 unknown.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Mary E. Klotman”): 396,956,012 for, 1,142,719 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 158,260,617 for, 18,186 against, 106,540 abstained, 34 not voted.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles

AMGEN INC.’s own tally for this item (“Elect Director: Ms. Amy E. Miles”): 387,072,432 for, 10,979,990 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 157,989,759 for, 286,122 against, 106,541 abstained, 34 not voted.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman

AMGEN INC.’s own tally for this item (“Elect Director: Ms. Ellen J. Kullman”): 389,710,003 for, 8,345,003 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2025 annual meeting of stockholders and un…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 225 asset managers below reported 158,016,851 for, 247,851 against, 114,800 abstained, 34 not voted.

Showing the 25 largest of 225 asset managers. See all 225 in the interactive database.

Description as filed by funds: To approve our Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.

AMGEN INC.’s own tally for this item (“3. To Approve Our Amgen Inc. Second Amended and Restated Equity Incentive Plan Our Amgen Inc. Second Amended and Restated Equity Incentive Plan”): 377,156,504 for, 20,285,985 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item 3 – To Approve Our Amgen Inc. Second Amended and Restated Equity Incentive Plan Our Amgen Inc. Second Amended and Restated Equity Incentive Plan was approved.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of AMGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (15 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 245 asset managers below reported 157,652,897 for, 680,105 against, 131,150 abstained, 34 not voted, 2,120 unknown.

Showing the 25 largest of 245 asset managers. See all 245 in the interactive database.

Description as filed by funds: Advisory vote to approve our executive compensation.

AMGEN INC.’s own tally for this item (“2. Advisory Vote to Approve Our Executive Compensation The advisory vote to approve our executive compensation”): 372,548,836 for, 24,800,740 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item 2 - Advisory Vote to Approve Our Executive Compensation The advisory vote to approve our executive compensation was approved.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of AMGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Section 14a Executive Compensation” (28 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Compensation” (2 managers, 5,200 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 213 managers: 157,422,092 for, 562,965 against, 121,582 abstained, 34 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 1,241 managers: 227,943,661 for, 16,261,148 against, 2,075 withheld, 97,309 abstained, 43,449 not voted, 469,006 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2024.

AMGEN INC.’s own tally for this item (“4. Ratification of Selection of Independent Registered Public Accountants Ernst & Young LLP”): 433,632,747 for, 28,413,909 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item 4 - Ratification of Selection of Independent Registered Public Accountants Ernst & Young LLP was ratified as the Company's independent registered public accountants for the fiscal year ending December 31, 2024.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of AMGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (7 managers, 31,622 for).

The 226 asset managers below reported 156,887,371 for, 1,374,429 against, 106,534 abstained, 34 not voted, 2,120 unknown.

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.